The clinical investigator

, Volume 70, Issue 9, pp 756–765 | Cite as

Molecular mechanisms involved in the etiology and pathogenesis of autoimmune diseases

  • M. Trucco
Molecular Medicine


Internal Medicine Molecular Mechanism Autoimmune Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



major histocompatibility complex


insulin-dependent diabetes mellitus


MHC molecule/peptide


antigen-presenting cell




γ interferon








t-cell receptor


human leukocyte antigens


islet cell antibody


glutamic acid decarboxylase


aspartic acid




ovalbumin peptide


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Allen PM, Babbitt BP, Unanue ER (1987) T-cell recognition of lysozyme: the biochemical basis of presentation. Immunol Rev 98:171–187.CrossRefGoogle Scholar
  2. 2.
    Atkinson MA, MacLaren NK, Scharp DW, Lacy PE, Riley WJ (1990) 64000 Mr autoantibodies as predictors of insulin-dependent diabetes. Lancet 335:1357–1360.CrossRefGoogle Scholar
  3. 3.
    Babbitt B, Allen G, Matsueda E, Haber E, Unanue E (1985) Binding of immunogenic peptides to la histocompatibility molecules. Nature 317:359–361.CrossRefGoogle Scholar
  4. 4.
    Baekkeskov S, Aanstoot HJ, Chritgau S, Reetz A, Solimena M, Cascahlo M, Folli F, Richter-Olesen H, Camilli PD (1990) Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347:151–156.CrossRefGoogle Scholar
  5. 5.
    Baisch JM, Weeks T, Giles R, Hoover M, Stastny P, Capra JD (1990) Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. N Engl J Med 322:1836–1841.CrossRefGoogle Scholar
  6. 6.
    Banga JP, Mahadevan D, Barton GJ, Sutton BJ, Saldanha JW, Odell E, McGregor AM (1990) Prediction of domain organization and secondary structure of thyroid peroxidase, a human autoantigen involved in destructive thyroiditis. FEBS Lett 266:133–141.CrossRefGoogle Scholar
  7. 7.
    Bao MZ, Wang JX, Dorman JS, Trucco M (1989) HLA-DQ beta non-ASP-57 allele and incidence of diabetes in China and the USA. Lancet II 497–498.CrossRefGoogle Scholar
  8. 8.
    Barnett AH Eff C, Leslie RDG, Pyke DA (1981) Diabetes in identical twins: a study of 200 pairs. Diabetologia 20: 87–92.CrossRefGoogle Scholar
  9. 9.
    Bertrams J, Baur M (1984) Insulin dependent diabetes mellitus. In: Albert ED, Baur MP, Mayr WR (eds) Histocompatibility testing 1984. Springer, Berlin Heidelberg New York, pp 348–358.CrossRefGoogle Scholar
  10. 10.
    Bjorkman P, Saper M, Samraoui B, Bennet W, Strominger J, Wiley D (1987) The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 329:512–517.CrossRefGoogle Scholar
  11. 11.
    Bjorkman P, Saper M, Samraoui W, Bennett W, Strominger J, Wiley D (1987) Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329:506–511.CrossRefGoogle Scholar
  12. 12.
    Blackman M, Kappler J, Marrack P (1990) The role of the T cell receptor in positive and negative selection of developing T cells. Science 248:1335–1341.CrossRefGoogle Scholar
  13. 13.
    Boehm B, Manfras B, Schöffling K, Seißler J, Glück M, Holzberger G, Seidl S, Kuehnl P, Trucco M, Scherbaum WA (1991) Epidemiology and immunogenetic background of islet cell antibody-positive nondiabetic schoolchildren: Ulm-Frankfurt population study. Diabetes 49:1435–1444.CrossRefGoogle Scholar
  14. 14.
    Boehm J, Schurbaur B, Kanagawa O, Benoist C, Mathis D (1990) MHC-linked protection from diabetes dissociated from clonal deletion of T cells. Science 20:293–296.CrossRefGoogle Scholar
  15. 14a.
    Boehmer H von, Kisielow P (1990) Self-nonself discrimination by T cells. Science 248:1369–1373.CrossRefGoogle Scholar
  16. 15.
    Bottazzo GF, Doniach D (1978) Islet cell antibodies in diabetes mellitus. Evidence of autoantigen common to all cells in the islet of Langerhans. Ric Clin Lab 8:29.PubMedGoogle Scholar
  17. 16.
    Bottazzo GF, Dean BM, McNally JM, Mackay EH, Swift PGF, Gamble DR (1985) In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas of diabetic insulitis. N Engl J Med 313:353–356.CrossRefGoogle Scholar
  18. 17.
    Brown J, Jardetzky T, Saper M, Samraoui B, Bjorkman P, Wiley D (1988) A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules. Nature 322:845–847.CrossRefGoogle Scholar
  19. 18.
    Burman P, Mardh S, Norberg L, Karlsson FA (1989) Parietal cell antibodies in pernicious anemia inhibit H+, K+-adenosine triphosphatase, the proton pump of the stomach. Gastroenterology 96:1434–1438.CrossRefGoogle Scholar
  20. 19.
    Carcassi C, Trucco G, Trucco M, Contu L (1991) A new HLA-DR2 extended haplotype is involved in insulin-dependent diabetes mellitus susceptibility. Hum Immunol 31:159–164.CrossRefGoogle Scholar
  21. 20.
    Contu L, Carcassi C, Trucco M (1991) Diabetes susceptibility in Sardinia. Lancet 338:65.CrossRefGoogle Scholar
  22. 21.
    Davis MM, Bjorkman PJ (1988) T-cell antigen receptor genes and T-cell recognition. Nature 334:395–402.CrossRefGoogle Scholar
  23. 22.
    Dorman J, LaPorte R, Stone R, Trucco M (1990) Worldwide differences in the incidence of Type I diabetes are associated with amino acid variation at position 57 of the HLA-DQ beta chain. Proc Natl Acad Sci USA 87:7370–7374.CrossRefGoogle Scholar
  24. 23.
    Drash AL (1988) Diabetes mellitus in the child and adolescent. In: Galloway JA, Shuman CR (eds) Diabetes mellitus, 9th edn. Lilly Research, Indianapolis.Google Scholar
  25. 24.
    Duquesnoy RJ, Trucco M (1988) Genetic basis of cell surface polymorphisms encoded by the major histocompatibility complex in humans. Crit Rev Immunol 8:103–145.PubMedGoogle Scholar
  26. 25.
    Fallis RJ, Raine CS, McFarlin DE (1989) Chronic relapsing experimental allergic encephalomyelitis in SJL mice following the adoptive transfer of an epitope-specific T cell line. J Neuroimmunol 22:93–105.CrossRefGoogle Scholar
  27. 26.
    Garrett TP, Saper MA, Bjorkman PJ, Strominger JL, Wiley DC (1989) Specificity pockets for the side chains of peptide antigens in HLA-Aw68. Nature 342:692–696.CrossRefGoogle Scholar
  28. 27.
    Germain RN (1990) Immunology. Making a molecular match. Nature 344:19–21.CrossRefGoogle Scholar
  29. 28.
    Giorda R, Peakman M, Tan KC, Vergani D, Trucco M (1991) Glutamic acid decarboxylase expression in islet and brain. Lancet 338:146.CrossRefGoogle Scholar
  30. 29.
    Giorda R, Turco E, Trucco M (1991) Full length beta chain cDNAs of DQw9 and DQw8 molecules encode proteins that differ only at amino acid 57. Immunogenetics 33:404–408.CrossRefGoogle Scholar
  31. 30.
    Gorga JG, Madden DR, Prendergast JK, Wiley DC, Strominger JL (1992) Crystallization and preliminary X-ray diffraction studies of the human histocompatibility antigen HLA-1327. Proteins 12:87–90.CrossRefGoogle Scholar
  32. 31.
    Gutierrez-Lopez MD, Bertera S, Chantres MT, Vavassori C, Dorman J, Trucco M, Serrano-Rios M (1992) Susceptibility to Type I diabetes in Spanish patients correlates quantitatively with expression of HLA-DQ alpha Arg 52 and HLA-DQ beta non-Asp 57 alleles. Diabetologia 35:583–588.CrossRefGoogle Scholar
  33. 32.
    Hedrick SM, Cohen DI, Nielsen EA, Davis MM (1984) Isolation of cDNA clones encoding T cell-specific membrane-associated proteins. Nature 308:149–153.CrossRefGoogle Scholar
  34. 33.
    Khalil I, d'Auriol L, Gobet M, Morin L, Lepage V, Deschamps I, Parks MS, Degos L, Galibert F, Hors J (1990) A combination of HLA-DQ beta Asp 57-negative and HLA-DQ alpha Arg 52 confers susceptibility to insulin-dependent diabetes mellitus. J Clin Invest 85:1315–1319.CrossRefGoogle Scholar
  35. 34.
    Klein J (1986) Natural history of the major histocompatibility complex. Wiley, New York.Google Scholar
  36. 35.
    Krohn K, Uibo R, Aavik E, Peterson P, Savilhati K (1992) Identification by molecular cloning of an autoantigen associated with Addison's disease as steroid 17-alpha-hydroxylase. Lancet 339:770–773.CrossRefGoogle Scholar
  37. 36.
    LaPorte RE, Tajima N, Akerblom HK, Berlin N, Brosseau J, Christy M, Drash AL, Fishbein H, Green A, Hamman R, Harris M, King H, Laron Z, Neil A (1985) Geographic differences in the risk of insulin-dependent diabetes mellitus: the importance of registries. Diabetes Care 101:101–107.CrossRefGoogle Scholar
  38. 37.
    Lipton R, LaPorte R, Dorman JS, Riley WJ, Drash AL, Becker DJ, Trucco M (1991) A combination of HLA-DQ-beta non-Asp 57 homozygosity and positive islet cell antibody (ICA) assay predicts insulin-dependent diabetes in relatives of children with IDDM. Diabetes 40 [Suppl 1]: 603.Google Scholar
  39. 38.
    Lund T, O'Reilly L, Hutchings P, Kanagawa O, Simpson E, Gravely R, Chandler P, Dyson J, Picard JK, Edwards A, Kioussis D, Cooke A (1990) Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A beta-chain or normal I-E alpha-chain. Nature 345:727–729.CrossRefGoogle Scholar
  40. 39.
    Lundin KEA, Qvigstad E, Ronningen KS, Thorsby E (1990) Antigen-specific T cells restricted by HLA-DQw8: importance of residue 57 of the DQ beta chain. Hum Immunol 28:397–405.CrossRefGoogle Scholar
  41. 40.
    Mellor AL, Weiss EH, Ramachandran K, Flavell RA (1983) A potential donor gene for the bm1 gene conversion event in the C57BL mouse. Nature 306:792–795.CrossRefGoogle Scholar
  42. 41.
    Morel PA, Dorman JS, Todd JA, McDevitt HO, Trucco M (1988) Aspartic acid at position 57 of the HLA-DQ-beta chain protects against Type I diabetes: a family study. Proc Natl Acad Sci USA 85:8111–8115.CrossRefGoogle Scholar
  43. 42.
    Neel JV, Shaw MW, Schull WJ (1965) The genetics and epidemiology of chronic diseases. Public Health Service Publications, Washington, D.C.Google Scholar
  44. 43.
    Nikolic-Zugic J, Bevan MJ (1990) Role of self-peptides in positively selecting the T-cell repertoire. Nature 344:65–71.CrossRefGoogle Scholar
  45. 44.
    Oldstone MBA (1987) Molecular mimicry and autoimmune diseases. Cell 50:819–820.CrossRefGoogle Scholar
  46. 45.
    Oldstone MBA, Nerenberg M, Southern P, Price J, Lewicki H (1987) Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 3:819–820.CrossRefGoogle Scholar
  47. 46.
    Ramsdell F, Fowlkes BJ (1990) Clonal deletion versus clonal anergy: the role of the thymus in inducing self tolerance. Science 248:1342–1348.CrossRefGoogle Scholar
  48. 47.
    Reich E, Sherwin RS, Kanagawa O, Janeway CA (1989) An explanation for the protective effect of the MHC class II-E molecule in murine diabetes. Nature 341:326–331.CrossRefGoogle Scholar
  49. 48.
    Rewers M, LaPorte RE, King HOM, Tuomilehto J (1988) Trends in the prevalence and incidence of diabetes: insulin-dependent diabetes mellitus in childhood. World Health Stat Q 41:171–190.Google Scholar
  50. 49.
    Ronningen LS, Halstensen TS, Spurkland A, Thorsby E (1989) The amino acid at position 57 of the HLA-DQ beta chain and susceptibility to develop IDDM. Hum Immunol 20:215–225.CrossRefGoogle Scholar
  51. 50.
    Salter RD, Benjamin RJ, Wesley PK, Buxton SE, Garrett TP, Clayberger C, Krensky AM, Norment AM, Littman DR, Parham P (1990) A binding site for the T-cell co-receptor CD8 on the alpha 3 domain of HLA-A2. Nature 345:41–46.CrossRefGoogle Scholar
  52. 51.
    Saper MA, Bjorkman PJ, Wiley DC (1991) Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 Å resolution. J Mol Biol 219:277–319.CrossRefGoogle Scholar
  53. 52.
    Schwartz RH (1990) A cell culture model for T lymphocyte clonal anergy. Science 248:1349–1356.CrossRefGoogle Scholar
  54. 53.
    Sheehy MJ, Shcarf SJ, Rowe JR, Neme de Gimenez MH, Mseke LM, Erlich HA, Nepom BS (1989) A diabetes susceptible HLA haplotype is best defined by a combination of HLA-DR and DQ alleles. J Clin Invest 83:830–835.CrossRefGoogle Scholar
  55. 54.
    Slattery RM, Kjer-Nielsen L, Allison J, Chariton B, Mandel TE, Miller JFAP (1990) Prevention of diabetes in non-obese diabetic I-Ak transgenic mice. Nature 345:724–726.CrossRefGoogle Scholar
  56. 55.
    Spielman RS, Baker L, Zmijewski CM (1980) Gene dosage and susceptibility to insulin-dependent diabetes. Ann Hum Genet 44:135–150.CrossRefGoogle Scholar
  57. 57.
    Stiller CR, Dupre J, Gent M, Jenner MR, Keown PA, Laupacis A, Martell R, Rodger NW, Graffenried B von, Wolfe BM (1984) Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset. Science 223:1362–1367.CrossRefGoogle Scholar
  58. 57.
    Sutherland DE, Goetz FC, Najarian ES (1984) Pancreas transplants from related donors. Transplantation 38:625–633.CrossRefGoogle Scholar
  59. 58.
    Swain SL (1983) T cell subsets and the recognition of MHC class. Immunol Rev 74:129–142.CrossRefGoogle Scholar
  60. 59.
    Todd JA, Bell JI, McDevitt HO (1987) HLA-DQ-beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329:559–564.CrossRefGoogle Scholar
  61. 60.
    Trucco M (1991) IDDM: etiology and diagnosis of an autoimmune disease. Diagnosis 3:5–26.Google Scholar
  62. 61.
    Trucco M (1992) Immunogenetics of insulin-dependent diabetes mellitus: the second event hypothesis. In: Belfiore F, Molinatti GM (ed) Frontiers of diabetes. Karger, Basel (in press).Google Scholar
  63. 62.
    Trucco M (1992) To be or not to be Asp 57, that is the question. Diabetes Care 15:705–715.CrossRefGoogle Scholar
  64. 63.
    Trucco M, Dorman JS (1989) Immunogenetics of insulin-dependent diabetes mellitus in humans. Crit Rev Immunol 9:201–245.PubMedGoogle Scholar
  65. 64.
    Weaver CT, Unanue ER (1990) The costimulatory function of antigen-presenting cells. Immunol Today 11:49–55.CrossRefGoogle Scholar
  66. 65.
    Weiss A, Imboden J, Hardy K, Manger B, Terhorst C, Stobo J (1986) The role of the T3/antigen receptor complex in T-cell activation. Annu Rev Immunol 4:593–619.CrossRefGoogle Scholar
  67. 66.
    Yoon JW (1986) Pediatric and adolescent endocrinology. Karger, Basel.Google Scholar
  68. 67.
    Zinkernagel R, Doherty P (1974) Immunological surveillance against altered self components by sensitized T-lymphocytic choriomeningitis. Nature 248:701–703.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1992

Authors and Affiliations

  • M. Trucco
    • 1
    • 2
  1. 1.Division of Immunogenetics, Department of PediatricsUniversity of Pittsburgh School of Medicine, and Rangos Research Center, Children's HospitalPittsburgh
  2. 2.Rangos Research Center Children's HospitalUniversity of Pittsburgh, School of MedicinePittsburghUSA

Personalised recommendations